Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Argos Announces One-for-Twenty Reverse Stock Split
- Nasdaq Panel Determines to Allow Continued Listing on The Nasdaq Capital Market Subject to Certain Conditions - 
From GlobeNewswire News Releases
Argos Announces $1.5 Million Equity Investment by Lummy (Hong Kong), Ltd.
Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision immunotherapy... 
From GlobeNewswire News Releases

Performance

More News

Read More
Factors of Influence in 2018, Key Indicators and Opportunity within Sonoco Products, Argos Therapeutics, CDW, Cenveo, CoBiz Financial, and Oppenheimer — New Research Emphasizes Economic Growth
From GlobeNewswire News Releases
Technical Perspectives on Argos Therapeutics, Omeros, Regulus Therapeutics, and Rhythm Pharma
From PR Newswire
Argos Provides Financial Update
From GlobeNewswire News Releases
Argos Therapeutics Provides Update on Immunology Data from the Phase 3 ADAPT Trial Presented at the SITC 2017 Annual Meeting
From GlobeNewswire News Releases
Argos Reports Third Quarter 2017 Financial Results and Operational Highlights
From GlobeNewswire News Releases
Argos Announces Receipt of Milestone Payment from Lummy (Hong Kong) Co. Ltd.
From GlobeNewswire News Releases
Argos Therapeutics to Report Third Quarter 2017 Financial Results and Operational Highlights on Thursday, November 9, 2017
From GlobeNewswire News Releases
Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors
From GlobeNewswire News Releases
Breakfast Technical Briefing on Biotech Stocks -- Amicus Therapeutics, Argos Therapeutics, Array BioPharma, and Aurinia Pharma
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.